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Abstract
In the last decade, tissue engineering is a field that has been suffering an enormous expansion in the regenera-
tive medicine and dentistry. The use of cells as mesenchymal dental stem cells of easy access for dentist and oral 
surgeon, immunosuppressive properties, high proliferation and capacity to differentiate into odontoblasts, cemen-
toblasts, osteoblasts and other cells implicated in the teeth, suppose a good perspective of future in the clinical 
dentistry. However, is necessary advance in the known of growth factors and signalling molecules implicated 
in tooth development and regeneration of different structures of teeth. Furthermore, these cells need a fabulous 
scaffold that facility their integration, differentiation, matrix synthesis and promote multiple specific interactions 
between cells. 
In this review, we give a brief description of tooth development and anatomy, definition and classification of stem 
cells, with special attention of mesenchymal stem cells, commonly used in the cellular therapy for their trasdif-
ferentiation ability, non ethical problems and acceptable results in preliminary clinical trials. 
In terms of tissue engineering, we provide an overview of different types of mesenchymal stem cells that have 
been isolated from teeth, including dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous 
teeth (SHEDs), periodontal ligament stem cells (PDLSCs), dental follicle progenitor stem cells (DFPCs), and stem 
cells from apical papilla (SCAPs), growth factors implicated in regeneration teeth and types of scaffolds for dental 
tissue regeneration.
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Introduction
The formation of the tooth is determined by the cells 
of which it is composed, the buccal epithelial cells that 
form the enamel organ and the mesenchymal cells that 
form the dental papilla. The enamel is formed by the 
enamel organ, and the dentin is formed by the dental pa-
pilla. Cells from the neural crest also take part in tooth 
formation. These cells originate in the nervous system 
and later migrate to the maxilla and mandible, where 
they interact with mesenchymal cells to form the enam-
el organ and the dental papilla (1,2). 
The tooth has two anatomical parts. The crown is the 
part of the tooth which is covered with enamel and it is 
the part usually visible in the mouth. The root is the part 
embedded in the jaw. It anchors the tooth in its bony 
socket and is normally not visible. The tissues of tooth 
are enamel, dentin, cementum and pulp. The pulp con-
tains blood vessels and nerves that enter the tooth from 
a hole at the apex of the root and cementum (Fig.1). 
Fig. 1. Tooth anatomy.
Around of tooth the periodontal ligament attaches the 
cementum to the alveolar (3). 
-Dental Pulp Tissue
Dental pulp is a loose connective tissue that occupies the 
pulp chamber of the tooth and originates in the embry-
onic dental papilla (ectomesenchymal tissue); it is the 
mature form of the papilla and the only smooth tissue of 
the tooth. The principal cell of this tissue is the odontob-
last, also referred to as the dentinoblast. The dental pulp 
also contains fibroblasts, undifferentiated mesenchymal 
cells or stem cells, macrophages, and lymphocytes (4).  
-Periodontal ligament (PDL)
The periodontal ligament (PDL) is a vascularised, cel-
lular soft connective tissue that surrounds the teeth and 
joins the root cementum with the hard sheet of the alveo-
lar bone (5). Most of the cells in the PDL are fibroblasts, 
which primarily function to synthesise and maintain 
the extracellular matrix. These fibroblasts contain a de-
veloped cytoskeleton of microtubules and actin micro-
filaments that has been implicated in cellular motility 
processes. In addition to fibroblasts, the PDL contains 
osteoblasts, osteoclasts, cementoblasts, macrophages, 
and stem cells that are capable of generating fibroblasts, 
cementoblasts, and osteoblasts (6,7).
Stem Cells
The term stem cell was proposed for scientific use by 
Russian histologist Alexander Maksimov in 1909. A-
lexander Maximov was the first to suggest the existence 
of hematopoietic stem cells (HSC) with the morphologi-
cal appearance of a lymphocyte, capable of migrating 
throughout the blood to microecological niches that 
would allow them to proliferate and differentiate along 
specific (8). While research on stem cells grew out of 
findings by Canadian scientists in the 1960s (8,9). Based 
on their origin, there are two main types of stem cells: 
embryonic stem cells (ES cells) and postnatal or adult 
stem cells (AS cells). Embryonic stem cells were har-
vested from embryos, they are cells derived from the in-
ner cell mass of the blastocyst (early stage embryo, 4-5 
days old, consist of 50-150 cells) of earlier morula stage 
embryo. In other words these are the cells that form the 
three germ layers, and are capable of developing more 
than 200 cell types. In 1998 the first human embryonic 
stem cell line was derived at university of Wisconsin-
Madison (10). 
Stem cells can be classified according to their abilities 
to differentiate as totipotent, pluripotent, or multipo-
tent. Totipotent stem cells are those that can be implant-
ed in the uterus of a living animal and give rise to a 
full organism. Pluripotent stem cells are those that can 
give rise to every cell of an organism except its extra-
embryonic tissues, such as the placenta. This limitation 
restricts pluripotent stem cells from developing into a 
full organism. Embryonic stem (ES) cells and induced 
pluripotent stem (iPS) cells are pluripotent stem cells. 
Multipotent stem cells are adult stem cells which only 
generate specific lineages of cells (11,12).
Embryonic stem cells have both moral and technical 
problems; because these cells will later develop into a 
human being, taking these cells will require destruc-
tion of an embryo. Technically these cells are difficult 
to control and grow and they might as well form tumors 
after their injection (13). Differentiating embryonic 
stem cells into usable cells while avoiding transplant 
rejection are just a few of the hurdles that embryonic 
stem cell researchers still face. And after ten years of re-
search, there are no approved treatments or human tri-
als using embryonic stem cells; but because of the com-
bined abilities of unlimited expansion and pluripotency, 
embryonic stem cells remain a theoretically potential 
source of regenerative medicine and tissue replacement 
after injury or disease (14).
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A very recent development, with potentially a profound 
significance for clinical therapy has been the generation 
of induced pluripotent stem (iPS) cells from somatic 
cells. The method for iPS cell induction is “ground-
breaking” because somatic cells are converted directly 
into pluripotent cells through introduction of four genes: 
Oct-4, Sox2, c-Myc and Klf4 (15). iPS cells have been 
shown to be similar to ES cells in morphology, proli-
feration and differentiation capacity and genomic and 
epigenomic states (16). 
To date, AS cells provide a promising tool for clinical 
applications in the near future due to their accessibility, 
despite their reduced plasticity (11). Although limited 
in their capability to differentiate, they can still develop 
into a number of cell lineages. The possibility of har-
vesting postnatal stem cells for later use in the same 
patient eliminates immunological difficulties and the 
risk of pathogen transmission. Adult stem cells from 
autologous origin are an appealing, and practical source 
for cell-based regenerative therapies that hold realistic 
clinical potential (11). 
-Mesenchymal Stem Cells
Alexander Friedenstein was the first to evidence the 
presence of a population of nonhematopoietic cells that 
were capable of autorenovation and bone differentiation 
in the bone marrow (17). Subsequently, others showed 
the bone-marrow-derived cells isolated according to 
Friedenstein’s technique, also possessed high potency 
of proliferation and pluripotency of differentiation 
into mesenchymal tissues, and therefore Caplan used 
the term ‘‘mesenchymal stem cell’’ (MSC) to describe 
them (18). Further studies have established mesenchy-
mal stem cells as a heterogeneous cell population in 
which each individual cell varies in its gene expression, 
differentiative capacity, expansion potential and pheno-
type (19,20). Moreover, all of them do not seem to fulfill 
the stem cell criteria. Therefore, they are preferred to 
be called ‘‘multipotent stromal cell’’ with the same ac-
ronym “MSC” (20). Several studies have demonstrated 
that MSCs can be isolated from multiple tissues, such 
as bone marrow, peripheral blood, umbilical cord blood, 
adult connective tissue, dental tissues, placenta, and 
amniotic membrane (21-24).
At present, any cell population which meets the follow-
ing characteristics, irrespective of its tissue source, is 
generally referred as MSC: morphologically, they ad-
here to plastic and have a fibroblast-like appearance; 
functionally, they have the ability of self-renewal and 
could differentiate into cells of the mesenchymal lin-
eage (osteocyte, chondrocyte and adipocyte), also into 
cells of the endoderm (hepatocytes) and ectoderm (neu-
rons) lineages under proper cell culture conditions; phe-
notypically, they express more than 95% of the popula-
tion express the CD105, CD73,CD90 surface antigens 
and that less than 2% of the population express the pan-
leukocyte marker CD45, the primitive hematopoietic 
progenitor and endothelial cell marker CD34, the mono-
cyte and macrophage markers CD14 and CD11, the B 
cell markers CD79 and CD19, or HLA class II (25).
-Tissue Engineering in Dentistry with Mesenchymal 
dental stem cells
Tissue engineering is an interdisciplinary field of study 
that applies the principles of engineering to biology and 
medicine toward the development of biological substi-
tutes that restore, maintain, and improve normal func-
tion (26). The emerging discipline of tissue engineering 
and regenerative medicine endeavors to use a rational ap-
proach based on morphogenetic signals for tissue induc-
tion, responding stem/progenitor cells and the scaffold to 
maintain and preserve the microenvironment (26).
Growth factors
Growth factors and signaling molecules have the abil-
ity to stimulate cellular proliferation and cellular differ-
entiation. Bone morphogenetic proteins (BMPs) family 
members are used sequentially and repeatedly through-
out embryonic tooth development, initiation, morpho-
genesis, cytodifferentiation and matrix secretion (26). 
Six different Bmps (Bmp2–Bmp7) are coexpressed 
temporally and spatially Bmp6 were identified in hu-
man primary culture of dental pulp cells (27). BMPs 
have been successfully applied for the regeneration of 
periodontal tissue (28), and other factors, such as PDGF, 
IGF-1, FGF-2, TGF-β, and BMPs (29), have utility in 
tooth tissue engineering. Dentin matrix protein-1, a 
non-collagenous protein involved in the mineralization 
process, induced cytodifferentiation, collagen produc-
tion and calcified deposits in dental pulp in a rat model 
(27). Other investigations have been demonstrated the 
effect of dexamethasone in cultures with dental stem 
cells, where these cells in combination with dexam-
ethasone can differentiate into osteoblasts, adipocytes 
or chondrocytes (30). Recently has been comproved the 
role of 17β-estradiol on cementoblast activity. An in 
vitro study with PDL fibroblasts showed enhanced al-
kaline phosphatase activity and mineralized nodule for-
mation when 17β-estradiol was added to the cell-culture 
medium (31).
Cell Source: Mesenchymal dental stem cells (MDSCs)  
To date, several types of adult stem cells have been 
isolated from teeth, including dental pulp stem cells 
(DPSCs) (32), stem cells from human exfoliated de-
ciduous teeth (SHEDs) (33), periodontal ligament stem 
cells (PDLSCs) (34), dental follicle progenitor stem 
cells (DFPCs) (35), and stem cells from apical papilla 
(SCAPs) (36). 
MDSCs are multipotent cells that proliferate extensive-
ly (maintained for at least 25 passages), can be safely 
cryopreserved, possess immunosuppressive properties, 
and express mesenchymal markers. MSDSCs can be 
isolated using explant cultures or enzymatic digestion. 
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In addition, the stem cells derived from teeth are large 
spindle-shaped cells with a large central nucleus abun-
dant cytoplasm, and cytoplasmic extensions in culture 
(Fig. 2). These adherent cells are morphologically iden-
Fig. 2. Spindle shaped dental stem cells in culture media. Phase con-
trast microscopy, original magnification: X100.
tical to the mesenchymal stem cells obtained from bone 
marrow (BMMSCs) (32). MDSCs can differentiate in 
vitro into cells of all of the germinal layers, including 
ectoderm (neural cells), mesoderm (myocytes, osteo-
blasts, chondrocytes, adipocytes, and cardiomyocytes), 
and endoderm (hepatic cells) (37). 
In 2000, Gronthos et al. (32) discovered a new type of 
stem cells from adult human dental pulp that have the 
ability to differentiate into odontoblasts/osteoblasts, 
adypocites and neural cells. These were termed den-
tal pulp stem cells (DPSC) (32). Transplanted ex vivo 
expanted DPSC mixed with hydroxyapatite/ tricalcium 
phosphate form ectopic dentin/pulp-like complexes in 
immunocompromised mice (32). These polls of hetero-
geneous DPSC form vascularizad pulp like tissue and 
are surrounded by a layer of odontoblast-like cells ex-
pressing factors that produce dentin containing tubules 
similar those found in natural dentin (32). In addition, 
DPSCs express mesenchymal markers as CD73, CD90 
and CD105 (37). Stem cells from human exfoliated de-
ciduous teeth (SHEDs), also termed immature, are MD-
SCs from dental pulp tissue of human deciduous teeth 
with the capacity to differentiate into osteogenic and 
odontogenic cells, adipocytes, and neural cells (32). As 
neural crest cell-associated postnatal stem cells, SHED 
express a variety of neural cell markers including nes-
tin, beta III tubulin, GAD, NeuN, GFAP, NFM, and 
CNPase (33). Also, SHED are able to form bone when 
transplanted in vivo  and may be an appropriate stem 
cell resource for treating immune disorders via im-
proved immunomodulatory properties (33). Periodon-
tal ligament stem cells (PDLSCs) isolated from human 
periodontal ligament also express mesenchymal mark-
ers. In vitro, PDLSCs have the ability to differentiate 
in vitro into adipogenic, osteogenic and chondrogenic 
cells (34). PDLSCs represent a novel stem cell popula-
tion in terms of in vivo capacity to differentiate into cells 
similar to cementoblasts and collagen-forming cells, as 
evidenced positively en preclinical studies (34). Dental 
follicle progenitor stem cells (DFPCs) obtained from a 
mesenchymal tissue that surrounds the developing tooth 
germ are multipotent stem cells that have immunomodu-
latory properties, high proliferation potential and ca-
pacity to differentiate into odontoblasts, cementoblasts, 
osteoblasts and other cells implicated in the teeth (35). 
Furthemore, are able to re-create a new periodontal 
ligament (PDL) after in vivo implantation (37).  Finally, 
the stem cells from apical papilla (SCAPs) isolated from 
a precursor of radicular pulp, express mesenchymal 
markers and can differentiate into odontoblast-like cells 
and produce dentin-like tissue in both in vitro and in 
vivo study systems (36). SCAP together with PDLSCs 
are able to form a root-like structure when seeded onto 
the hydroxyapatite-based scaffold and implanted in pig 
jaws (37). 
Scaffold
Actually, investigators search the “ideal scaffold” to 
facilitate the growth, integration and differentiation of 
stem cells. The scaffold should be biocompatible, non-
toxic and have optimal physical features and mechani-
cal properties. Experiments with cell-free scaffolds 
are especially attractive because of an easier handling 
process that eliminates the issues associated with the 
use of stem cells and their expansion in vitro, with stor-
age and shelf-life, cost aspects, immunoresponse of the 
host and transmission of diseases (38). However there 
are some disvantages in this method: first, the cells may 
have low survival rates. Second, the cells might migrate 
to different locations within the body, possibly leading 
to aberrant patterns to mineralization. A solution for 
this problem may be to apply the cells together with a 
scaffold. This would help to position and maintain cell 
localization (39).
Many materials have been designed and constructed for 
tissue engineering approaches, namely natural and syn-
thetic polymers or inorganic materials and composites, 
which have been fabricated into porous scaffolds, nanofi-
brous materials, microparticles and hydrogels. Natural 
materials include collagen, elastin, fibrin, alginate, silk, 
glycosaminoglycans such as hyaluronan, and chitosan 
(40). They offer a high degree of structural strength, are 
compatible with cells and tissues and biodegradable, but 
are often difficult to process and afflicted with the risk 
of transmitting animal-associated pathogens or provok-
ing an immunoresponse. Synthetic polymers as poly 
lactic acid (PLA), poly glycolic acid (PGA), and their 
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copolymer, poly lactic-co-glycolic acid (PLGA) provide 
excellent chemical and mechanical properties and allow 
high control over the physicochemical characteristics, 
such as molecular weight, configuration of polymer 
chains, or the presence of functional groups.  Recently, 
hydrogels have been explored for tissue engineering 
applications in more detail. Hydrogels offer numerous 
interesting properties including high biocompatibility, a 
tissue-like water content and mechanical characteristics 
similar to those of native tissue (40).
Conclusions
Mesenchymal Dental Stem cells derived from teeth are 
easily accessible multipotent cells with the capacity to 
differentiate into distinct cell types. This new source 
of stem cells could be of benefit in cellular therapy and 
the eventual development of techniques for use in re-
generative dentistry and degenerative diseases. Future 
studies will probably focus on subpopulations of stem 
cells derived from teeth characterized by specific sur-
face markers, their distinctive properties and their use 
in clinical applications.
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